Palbociclib (P) in advanced acral lentiginous melanoma (ALM) with CDK4 pathway gene aberrations.

被引:6
|
作者
Mao, Lili
Cao, Yabing
Sheng, Xinan
Bai, Xue
Chi, Zhihong
Cui, Chuanliang
Wang, Xuan
Tang, Bixia
Lian, Bin
Yan, Xieqiao
Li, Siming
Zhou, Li
Wei, Xiaoting
Li, Caili
Qi, Zhong Hui
Si, Lu
Guo, Jun
机构
[1] Peking Univ Canc Hosp & Inst, Dept Renal Canc & Melanoma, Collaborat Innovat Ctr Canc Med, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China
[2] Kiang Wu Hosp, Macau, Peoples R China
[3] Peking Univ, Canc Hosp, Beijing, Peoples R China
[4] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
关键词
D O I
10.1200/JCO.2019.37.15_suppl.9528
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9528
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Prevalent aberrations of CDK4 pathway in acral melanoma and implications for targeted therapy.
    Kong, Yan
    Sheng, Xinan
    Wu, Xiaowen
    Si, Lu
    Ma, Meng
    Yu, Jiayi
    Chi, Zhihong
    Cui, Chuanliang
    Dai, Jie
    Li, Yiqian
    Yan, Junya
    Yu, Huan
    Xu, Tianxiao
    Tang, Huan
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy
    Kong, Yan
    Sheng, Xinan
    Wu, Xiaowen
    Yan, Junya
    Ma, Meng
    Yu, Jiayi
    Si, Lu
    Chi, Zhihong
    Cui, Chuanliang
    Dai, Jie
    Li, Yiqian
    Yu, Huan
    Xu, Tianxiao
    Tang, Huan
    Tang, Bixia
    Mao, Lili
    Lian, Bin
    Wang, Xuan
    Yan, Xieqiao
    Li, Siming
    Guo, Jun
    CLINICAL CANCER RESEARCH, 2017, 23 (22) : 6946 - 6957
  • [3] Genetic aberrations in the CDK4 pathway and association with innate resistance to PD-1 blockade in acral melanoma
    Yu, Jiayi
    Kong, Yan
    Chi, Zhihong
    Tang, Bixia
    Sheng, Xinan
    Si, Lu
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Original Research Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway
    Mao, Lili
    Dai, Jie
    Cao, Yabin
    Bai, Xue
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Kong, Yan
    Zhang, Yanxiang
    Wu, Lin
    Wang, Xuan
    Tang, Bixia
    Lian, Bin
    Yan, Xieqiao
    Li, Siming
    Zhou, Li
    Wei, Xiaoting
    Li, Caili
    Qi, Zhonghui
    Si, Lu
    Guo, Jun
    EUROPEAN JOURNAL OF CANCER, 2021, 148 : 297 - 306
  • [5] Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case report
    Tang, Bixia
    Sheng, Xinan
    Kong, Yan
    Chi, Zhihong
    Si, Lu
    Cui, Chuanliang
    Yan, Xieqiao
    Mao, Lili
    Lian, Bin
    Li, Siming
    Wang, Xuan
    Dai, Jie
    Bai, Xue
    Zhou, Li
    Guo, Jun
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (06)
  • [6] ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma
    Kasturee Jagirdar
    Marie E. Portuallo
    Meihan Wei
    Matthew Wilhide
    Jeremy A. Bravo Narula
    Bailey M. Robertson
    Gretchen M. Alicea
    Crystal Aguh
    Min Xiao
    Tetiana Godok
    Dylan Fingerman
    Gregory Schuyler Brown
    Meenhard Herlyn
    Vissy M. Elad
    Xinyu Guo
    Eneda Toska
    Daniel J. Zabransky
    Bradley Wubbenhorst
    Katherine L. Nathanson
    Shawn Kwatra
    Yogesh Goyal
    Hongkai Ji
    Qin Liu
    Vito W. Rebecca
    Oncogene, 2024, 43 : 395 - 405
  • [7] ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma
    Jagirdar, Kasturee
    Portuallo, Marie E.
    Wei, Meihan
    Wilhide, Matthew
    Bravo Narula, Jeremy A.
    Robertson, Bailey M.
    Alicea, Gretchen M.
    Aguh, Crystal
    Xiao, Min
    Godok, Tetiana
    Fingerman, Dylan
    Brown, Gregory Schuyler
    Herlyn, Meenhard
    Elad, Vissy M.
    Guo, Xinyu
    Toska, Eneda
    Zabransky, Daniel J.
    Wubbenhorst, Bradley
    Nathanson, Katherine L.
    Kwatra, Shawn
    Goyal, Yogesh
    Ji, Hongkai
    Liu, Qin
    Rebecca, Vito W.
    ONCOGENE, 2024, 43 (06) : 395 - 405
  • [8] p27 ACTIVATES CDK4 AND BLOCKS PALBOCICLIB-MEDIATED CDK4 INHIBITION
    不详
    CANCER DISCOVERY, 2020, 10 (02) : 172 - 172
  • [9] CDK4 gene copy number increase and concurrent genetic changes in acral melanoma of a Chinese cohort
    Yang, Leyuan
    Liu, Yan
    Guo, Ruiping
    Du, Juan
    Liu, Lingchao
    Liu, Xiaolong
    Zhao, Jianfang
    Shi, Fang
    Zhang, Xin
    Su, Jing
    PATHOLOGY, 2025, 57 (01) : 34 - 39
  • [10] An analysis of p16 tumour suppressor gene expression in acral lentiginous melanoma
    Chana, JS
    Grover, R
    Wilson, GD
    Hudson, DA
    Forders, M
    Sanders, R
    Grobbelaar, AO
    BRITISH JOURNAL OF PLASTIC SURGERY, 2000, 53 (01): : 46 - 50